Proprietary Service · Intusomics Analytics
You have experimental results with real potential. We turn them into a scientifically robust, multi-cohort evidence package, ready for patent filing, regulatory submission, or licensing negotiation.
Request a confidential consultationNDA available upon request · All projects under strict confidentiality
What we protect
The challenge
Not because the science isn't there, but because turning experimental data into defensible industrial property requires a very specific combination of statistical depth, biological interpretation, and external validation.
Your team has identified a signal: a differentially expressed gene, a novel biomarker candidate, an unexpected phenotype. But there is no clear path to industrial application.
Patent examiners and licensing partners expect multi-cohort evidence. A single internal dataset (however robust) is rarely sufficient to build a defensible IP claim.
Legal and IP professionals speak a different language than researchers. Translating omics findings into a scientifically airtight, legally actionable document requires a specific kind of expertise.
What you receive
We start from your raw results and apply rigorous statistical and bioinformatic frameworks to extract every layer of biological meaning, beyond what standard pipelines surface.
We systematically search and analyse curated public databases to identify independent cohorts that corroborate your findings, building the external evidence base your patent requires.
A structured, comprehensive document presenting the statistical evidence, the biological rationale, and the novelty of your finding, written to be directly usable by your IP legal team.
All results are delivered as fully interactive visualizations, allowing you to explore, present, and defend your findings in meetings with investors, partners, or patent examiners.
We remain available throughout the patent process to respond to examiner queries, produce supplementary analyses, or adapt the evidence package to new requirements.
Why external validation matters
Every project uses independent, peer-reviewed datasets, ensuring your evidence package is scientifically unimpeachable and legally defensible.
Who we work with
Academic & Clinical Research Groups
"We published the paper — but the real commercial potential of our data hasn't been exploited yet."
Research groups that have generated valuable omics datasets and suspect their findings have industrial applications, but lack the resources or expertise to build a patent case. We help you turn your academic output into an asset you own.
Biotech & Pharma R&D Teams
"Our internal data shows something real — but we need external corroboration before we can file."
R&D teams that have identified a promising target or biomarker from internal studies and need a rigorous, independent validation package to support a patent filing, licensing deal, or regulatory submission.
Every project begins with a mutual NDA. Your data, your findings, and the existence of the engagement itself remain strictly confidential throughout and after the project.
Get in touch
Tell us about your data and what you are hoping to protect. There is no commitment at this stage, just a confidential conversation to assess whether we can help.
We respond within 24–48 hours.
Confidential Consultation Request